Controversies in lung transplantation: management of cytomegalovirus infections
- 1 August 2002
- journal article
- review article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 21 (8) , 841-849
- https://doi.org/10.1016/s1053-2498(02)00435-7
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- THE ECONOMIC IMPACT OF CYTOMEGALOVIRUS INFECTION AFTER LIVER TRANSPLANTATIONTransplantation, 2000
- Influence of anti‐rejection therapy on the timing of cytomegalovirus disease and other infections in renal transplant recipientsClinical Transplantation, 2000
- Infection in solid organ transplantationTransplant Infectious Disease, 1999
- Infection in Organ-Transplant RecipientsNew England Journal of Medicine, 1998
- CYTOMEGALOVIRUS DISEASE IS ASSOCIATED WITH INCREASED COST AND HOSPITAL LENGTH OF STAY AMONG ORTHOTOPIC LIVER TRANSPLANT RECIPIENTS1Transplantation, 1997
- Summary of the international consensus symposium on advances in the diagnosis, treatment and prophylaxis of cytomegalovirus infectionAntiviral Research, 1996
- A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.American Journal of Respiratory and Critical Care Medicine, 1994
- THE COST IMPACT OF CYTOMEGALOVIRUS DISEASE IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1993
- Sequelae of Cytomegalovirus Pulmonary Infections in Lung Allograft RecipientsAmerican Review of Respiratory Disease, 1992
- Cytomegalovirus infections in heart and heart-lung transplant recipientsJournal of Antimicrobial Chemotherapy, 1989